Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,358 | -3,765 | -1,856 | -1,917 | -2,983 |
| Depreciation Amortization | 806 | 8 | 25 | 1 | 239 |
| Income taxes - deferred | -603 | -903 | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | -4 |
| Accounts payable and accrued liabilities | -217 | 241 | 10 | 4 | 5 |
| Other Working Capital | -180 | 189 | 161 | -239 | 154 |
| Other Operating Activity | 801 | 521 | 5 | -4 | 1,717 |
| Operating Cash Flow | $-2,750 | $-3,708 | $-1,655 | $-2,155 | $-872 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,019 | -1,019 | N/A |
| PPE Investments | N/A | N/A | -21 | -24 | -1 |
| Net Acquisitions | N/A | N/A | 6 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -22 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -22 | 0 | 0 | 42 |
| Investing Cash Flow | $N/A | $-22 | $1,005 | $-1,043 | $40 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 805 | N/A | 2,580 | N/A | 753 |
| Debt Repayment | N/A | N/A | N/A | N/A | -20 |
| Common Stock Issued | N/A | 2,875 | N/A | 4,270 | 88 |
| Other Financing Activity | 896 | -251 | -155 | 0 | 0 |
| Financing Cash Flow | $1,701 | $2,624 | $2,425 | $4,270 | $821 |
| Beginning Cash Position | 1,741 | 2,847 | 1,072 | N/A | 25 |
| End Cash Position | 692 | 1,741 | 2,847 | 1,072 | 14 |
| Net Cash Flow | $-1,049 | $-1,107 | $1,776 | $1,072 | $-11 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,750 | -3,708 | -1,655 | -2,155 | -872 |
| Capital Expenditure | N/A | N/A | -21 | -24 | -1 |
| Free Cash Flow | -2,750 | -3,708 | -1,675 | -2,179 | -873 |